Cellbiocontrol Laboratory, Department of Medical Engineering, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea; Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea.
Cellbiocontrol Laboratory, Department of Medical Engineering, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Republic of Korea.
Acta Biomater. 2017 Jan 15;48:175-185. doi: 10.1016/j.actbio.2016.10.024. Epub 2016 Oct 18.
Although a number of natural materials have been used as hemostatic agents, many substances do not act quickly enough. Here, we created a novel dressings using collagen and chitosan with recombinant batroxobin (r-Bat) to promote faster and more effective hemostasis. We hypothesized that r-Bat would promote synergetic blood coagulation because it contains a blood coagulation active site different than those of collagen and chitosan. Our results suggest that each substances can maintain hemostatic properties while in the mixed dressings and that our novel hemostatic dressings promotes potent control of bleeding, as demonstrated by a whole blood assay and rat hemorrhage model. In a rat femoral artery model, the scaffold with a high r-Bat concentration more rapidly controlled excessive bleeding. This novel dressings has enormous possible for rapidly controlling bleeding and it improves upon the effect of collagen and chitosan used alone. Our novel r-Bat dressings is a possible candidate for improving preoperative care and displays promising properties as an absorbable agent in hemostasis.
Despite the excellent hemostatic properties of collagen and chitosan pads, they reported to brittle behavior and lack sufficient hemostatic effect within relevant time. Therefore, we created a novel pad using collagen and chitosan with recombinant batroxobin (r-Bat). r-Bat acts as a thrombin-like enzyme in the coagulation cascade. Specifically, r-Bat, in contrast to thrombin, only splits fibrinopeptide A off and does not influence other hemostatic factors or cells, which makes it clinically useful as a stable hemostatic agent. Also the materials in the pad have synergetic effect because they have different hemostatic mechanisms in the coagulation cascade. This report propose the novel hemostatic pad isreasonable that a great potential for excessive bleeding injury and improve effects of natural substance hemostatic pad.
虽然有许多天然材料已被用作止血剂,但许多物质的作用速度不够快。在这里,我们使用胶原蛋白和壳聚糖与重组蝙蝠酶(r-Bat)创建了一种新型敷料,以促进更快更有效的止血。我们假设 r-Bat 会促进协同的血液凝固,因为它含有与胶原蛋白和壳聚糖不同的血液凝固活性部位。我们的结果表明,每种物质在混合敷料中都可以保持止血特性,并且我们的新型止血敷料可以有效地控制出血,这可以通过全血测定和大鼠出血模型来证明。在大鼠股动脉模型中,具有高 r-Bat 浓度的支架可更快地控制过度出血。这种新型敷料具有迅速控制出血的巨大潜力,并改善了胶原蛋白和壳聚糖单独使用的效果。我们的新型 r-Bat 敷料可能是改善术前护理的候选物,并作为止血中的可吸收剂显示出有前途的特性。
尽管胶原蛋白和壳聚糖垫具有出色的止血性能,但它们报告的脆性行为和缺乏足够的止血效果在相关时间内。因此,我们使用胶原蛋白和壳聚糖与重组蝙蝠酶(r-Bat)创建了一种新型垫。r-Bat 在凝血级联中充当类凝血酶酶。具体来说,与凝血酶不同,r-Bat 仅将纤维蛋白肽 A 分裂下来,并且不影响其他止血因子或细胞,这使其在临床上可用作稳定的止血剂。垫中的材料也具有协同作用,因为它们在凝血级联中具有不同的止血机制。本报告提出了新型止血垫具有合理性,它具有很大的潜力,可以用于治疗过度出血损伤,并改善天然物质止血垫的效果。